Authors:
Papillon, E
Rolachon, A
Calender, A
Chabre, O
Barnoud, R
Fournet, J
Citation: E. Papillon et al., A malignant gastrointestinal stromal tumour in a patient with multiple endocrine neoplasia type 1, EUR J GASTR, 13(2), 2001, pp. 207-211
Citation: E. Papillon et al., Antitumoral immunotherapy and gastrointestinal tract: specific immunotherapy using dendritic cells and potential interest of heat shock proteins, GASTRO CL B, 25(4), 2001, pp. 380-390
Authors:
Galmiche, JP
Zerbib, F
Ducrotte, P
Fournet, J
Rampal, P
Avasthy, N
Humphries, TJ
Citation: Jp. Galmiche et al., Decreasing oesophageal acid exposure in patients with GERD: a comparison of rabeprazole and omeprazole, ALIM PHARM, 15(9), 2001, pp. 1343-1350
Authors:
Bonaz, B
Riviere, PJM
Sinniger, V
Pascaud, X
Junien, JL
Fournet, J
Feuerstein, C
Citation: B. Bonaz et al., Fedotozine, a kappa-opioid agonist, prevents spinal and supra-spinal Fos expression induced by a noxious visceral stimulus in the rat, NEUROG MOT, 12(2), 2000, pp. 135-147
Citation: A. Rolachon et al., Is argon plasma coagulation an efficient treatment for digestive vascular malformation and radiation proctitis?, GASTRO CL B, 24(12), 2000, pp. 1205-1210
Citation: E. Papillon et al., Short chain fatty acids (SCFA): effects on gastrointestinal function and therapeutic potential in Gastroenterology, GASTRO CL B, 23(6-7), 1999, pp. 761-769
Citation: J. Fournet, Can spontaneous course and therapeutic response be predicted in gastro-esophageal reflux disease?, GASTRO CL B, 23(1BIS), 1999, pp. S61-S66
Authors:
Spencer, J
Hersch, G
Eschenfelder, V
Fournet, J
Murray-Gerzik, M
Citation: J. Spencer et al., Outcomes of protocol-based and adaptation-based occupational therapy interventions for low-income elderly persons on a transitional unit, AM J OCCU T, 53(2), 1999, pp. 159-170